| Description | DNA Methylation Magnetic Beads are magnetic solid-phase carriers specifically designed for DNA methylation processing workflows. Utilizing a specialized manufacturing process, these beads exhibit high specificity, large surface area, and strong magnetic properties, combined with exceptional DNA Methylation Magnetic Beads are magnetic solid-phase carriers specifically designed for DNA methylation processing workflows. Utilizing a specialized manufacturing process, these beads exhibit high specificity, large surface area, and strong magnetic properties, combined with exceptional hydrophilicity and nucleic acid capture capacity.This product demonstrates excellent extraction efficiency for bisulfite-treated DNA (e.g., via sodium bisulfite conversion) and is compatible with automated liquid-phase nucleic acid extraction platforms. It is widely used in life science research and applications involving epigenetic studies.Key Features✔ Excellent handling performance.✔ High specificity for bisulfite-converted DNA.✔ Superior reproducibility.ProtocolAdd an appropriate volume of magnetic beads and binding buffer to bisulfite-treated DNA samples.Incubate to allow nucleic acid binding.Separate bead-bound nucleic acids from unbound materials using magnetic separation.Wash beads with wash buffer to remove impurities; retain beads using a magnet.Elute nucleic acids with elution buffer; separate beads from the final product magnetically.PrecautionsAvoid freezing, drying, or centrifugation – these may cause bead aggregation and affect resuspension.Vortex thoroughly before use to ensure a homogeneous suspension.Storage:Stable for 2 years at 2–8°C.Slight color variations under normal storage conditions do not affect performance... Read More | Inquire | Purity>95% SDS-PAGEFunctionLipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid. Delivers long-chain fatty acids and retinoic acid to their cognate receptors in the nucleus | Purity> 95 % by SDS-PAGE and HPLC analyses.FunctionOsteoprotegerin (OPG), also named osteoclastogenesis inhibitory factor (OCIF), and tumor necrosis factor receptor superfamily member 11B (TNFRSF11B), is a TNFRSF11B-encoded protein in humans. Acts as decoy receptor for RANKL and thereby Purity> 95 % by SDS-PAGE and HPLC analyses.FunctionOsteoprotegerin (OPG), also named osteoclastogenesis inhibitory factor (OCIF), and tumor necrosis factor receptor superfamily member 11B (TNFRSF11B), is a TNFRSF11B-encoded protein in humans. Acts as decoy receptor for RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local RANKL/OPG ratio. May also play a role in preventing arterial calcification. May act as decoy receptor for TRAIL and protect against apoptosis. TRAIL binding blocks the inhibition of osteoclastogenesis.OPG has been applied to decrease bone resorption in women with postmenopausal osteoporosis and in patients with lytic bone metastases... Read More | Inquire |